CurrentEndo
Get Weekly

Topic · page 95 of 119

Type 2 & other diabetes

Type 2 diabetes and prediabetes: prevention, remission, glucose-lowering drugs, weight-based treatment, insulin, lifestyle and diet; monogenic and other specific types of diabetes

Briefs 3,761–3,800 of 4,758 placed here, newest publication first

Briefs in Type 2 & other diabetes

Newest publication first

  1. Diabetes Obes Metab

    Efficacy and safety of cetagliptin as monotherapy in patients with type 2 diabetes: A randomized, double‐blind, placebo‐controlled phase 3 trial

    Randomized controlled trial

  2. Obesity (Silver Spring)

    Genome‐wide polygenic risk score, cardiometabolic risk factors, and type 2 diabetes mellitus in the Chinese population

    Cohort study

  3. Cardiovasc Diabetol

    Left ventricular remodeling response to SGLT2 inhibitors in heart failure: an updated meta-analysis of randomized controlled studies

    Meta-analysis

  4. Diabet Med

    Causes of death among Australians with type 1 or type 2 diabetes, 2002–2019

    Cohort study

  5. Cardiovasc Diabetol

    Microvascular endothelial dysfunction in skin is associated with higher risk of heart failure with preserved ejection fraction in women with type 2 diabetes: the Hoorn Diabetes Care System Cohort

    Cross-sectional study

  6. Diabetes Obes Metab

    The rest‐activity rhythm, genetic susceptibility and risk of type 2 diabetes: A prospective study in UK Biobank

    Cohort study

  7. Diabet Med

    Diagnosis and treatment of anti‐insulin antibody‐mediated labile glycaemia in insulin‐treated diabetes

    Diagnostic or prognostic study

  8. Diabetologia

    Bringing precision medicine to the management of pregnancy in women with glucokinase-MODY: a study of diagnostic accuracy and feasibility of non-invasive prenatal testing

    Diagnostic or prognostic study

  9. Diabetes Care

    Effect of Conventional Lifestyle Interventions on Type 2 Diabetes Incidence by Glucose-Defined Prediabetes Phenotype: An Individual Participant Data Meta-analysis of Randomized Controlled Trials

    Meta-analysis

  10. Cardiovasc Diabetol

    Empagliflozin is associated with lower cardiovascular risk compared with dipeptidyl peptidase-4 inhibitors in adults with and without cardiovascular disease: EMPagliflozin compaRative effectIveness and SafEty (EMPRISE) study results from Europe and Asia

    Cohort study

  11. Cardiovasc Diabetol

    Triglyceride-glucose index in the prediction of adverse cardiovascular events in patients without diabetes mellitus after coronary artery bypass grafting: a multicenter retrospective cohort study

    Cohort study

  12. Diabetes Obes Metab

    Comparison of clinical efficacy and safety of weekly glucagon‐like peptide‐1 receptor agonists dulaglutide and semaglutide in Japanese patients with type 2 diabetes: Randomized, parallel‐group, multicentre, open‐label trial ( COMING study)

    Randomized controlled trial

  13. Diabetes Obes Metab

    Cardiovascular efficacy and safety of antidiabetic agents: A network meta‐analysis of randomized controlled trials

    Meta-analysis

  14. Diabetes Care

    Methyl Donor Nutrient Intake and Incidence of Type 2 Diabetes: Results From Three Large U.S. Cohorts

    Cohort study

  15. Cardiovasc Diabetol

    Long-term cardiovascular outcomes of biodegradable polymer drug eluting stents in patients with diabetes versus non-diabetes mellitus: a meta-analysis

    Meta-analysis

  16. Diabetes Care

    The Relationship Between Time-Varying Achieved HbA1c and Risk of Coronary Events Depends on Haptoglobin Phenotype Among White and Black ACCORD Participants

    Secondary analysis

  17. Cardiovasc Diabetol

    Association of prior outpatient diabetes screening with cardiovascular events and mortality among people with incident diabetes: a population-based cohort study

    Cohort study

  18. Diabetes Care

    Genome-Wide Association Study Identifies Pharmacogenomic Variants Associated With Metformin Glycemic Response in African American Patients With Type 2 Diabetes

    Meta-analysis

  19. Diabetes Care

    Duration of Type 2 Diabetes and Incidence of Cancer: An Observational Study in England

    Cohort study

  20. BMJ Open Diabetes Res Care

    Glomerular filtration rate in patients with type 2 diabetes mellitus: is serum isthmin-1 level a possible link?

    Cohort study

  21. Diabet Med

    Diabetes knowledge, self‐efficacy and dietary, psychological and physical health barriers: Comparing young and usual‐onset type 2 diabetes

    Cross-sectional study

  22. Diabet Med

    Views of children with diabetes from underserved communities, and their families on diabetes, glycaemic control and healthcare provision: A qualitative evidence synthesis

    Meta-analysis

  23. Diabet Med

    Glucose‐lowering treatment pathways of individuals with chronic kidney disease and type 2 diabetes according to the Kidney Disease: Improving Global Outcomes 2012 risk classification

    Cohort study

  24. J Clin Endocrinol Metab

    Long-term Outcomes of Testosterone Treatment in Men: A T4DM Postrandomization Observational Follow-up Study

    Randomized controlled trial

  25. Diabetes Care

    Age at Type 2 Diabetes Diagnosis and Cause-Specific Mortality: Observational Study of Primary Care Patients in England

    Cohort study

  26. Diabetes Obes Metab

    Efficacy and safety of the sodium‐glucose co‐transporter‐2 inhibitor empagliflozin in elderly Japanese adults (≥65 years) with type 2 diabetes: A randomized, double‐blind, placebo‐controlled, 52‐week clinical trial ( EMPA‐ELDERLY )

    Randomized controlled trial

  27. Cardiovasc Diabetol

    Effect of semaglutide on major adverse cardiovascular events by baseline kidney parameters in participants with type 2 diabetes and at high risk of cardiovascular disease: SUSTAIN 6 and PIONEER 6 post hoc pooled analysis

    Meta-analysis

  28. Cardiovasc Diabetol

    Circulating PCSK9 as a prognostic biomarker of cardiovascular events in individuals with type 2 diabetes: evidence from a 16.8-year follow-up study

    Cohort study

  29. Cardiovasc Diabetol

    Machine learning profiles of cardiovascular risk in patients with diabetes mellitus: the Silesia Diabetes-Heart Project

    Cohort study

  30. Diabet Med

    Risk prediction of bladder cancer among person with diabetes: A derivation and validation study

    Diagnostic or prognostic study

  31. Diabetes Obes Metab

    Safety and effectiveness of dulaglutide in Chinese adults with type 2 diabetes mellitus in a real‐world setting: A prospective, observational post‐marketing study

    Cohort study

  32. BMJ Open Diabetes Res Care

    Association of body indices and risk of mortality in patients with type 2 diabetes

    Cohort study

  33. Diabetes Obes Metab

    A multicomponent health care intervention is associated with improved glycaemic control in subjects with poorly controlled type 2 diabetes compared with routine care: The INTEGRA study

    Cohort study

  34. Diabetes Obes Metab

    Pharmacogenetics of sodium‐glucose co‐transporter‐2 inhibitors: Validation of a sex‐agnostic pharmacodynamic biomarker

    Research article

  35. J Clin Endocrinol Metab

    Tirzepatide in Hispanic/Latino Patients With Type 2 Diabetes: A Subgroup Analysis of the SURPASS Program

    Secondary analysis

  36. Endocr Pract

    Effect of Metformin Use on Vitamin B12 Deficiency Over Time (EMBER): A Real-World Evidence Database Study

    Cohort study

  37. Diabetes Res Clin Pract

    Factors associated with therapeutic inertia in individuals with type 2 diabetes mellitus started on basal insulin

    Cohort study

  38. Cardiovasc Diabetol

    Intravenous ferric carboxymaltose for iron repletion following acute heart failure in patients with and without diabetes: a subgroup analysis of the randomized AFFIRM-AHF trial

    Secondary analysis

  39. Cardiovasc Diabetol

    Clusters of prediabetes and type 2 diabetes stratify all-cause mortality in a cohort of participants undergoing invasive coronary diagnostics

    Cohort study

  40. Cardiovasc Diabetol

    A six-month low-carbohydrate diet high in fat does not adversely affect endothelial function or markers of low-grade inflammation in patients with type 2 diabetes: an open-label randomized controlled trial

    Randomized controlled trial

All 4,758 Briefs in ExploreShowing Briefs 3,761–3,800 of 4,758, newest first